Hubbry Logo
Augusto, Michaela, and Lorenzo OdoneAugusto, Michaela, and Lorenzo OdoneMain
Open search
Augusto, Michaela, and Lorenzo Odone
Community hub
Augusto, Michaela, and Lorenzo Odone
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Augusto, Michaela, and Lorenzo Odone
Augusto, Michaela, and Lorenzo Odone
Augusto, Michaela, and Lorenzo Odone
View on Wikipedia
from Wikipedia

Key Information

Michaela Odone
BornMichaela Teresa Murphy
(1939-01-10)January 10, 1939
Yonkers, New York, US
DiedJune 10, 2000(2000-06-10) (aged 61)
Fairfax, Virginia, US
Known forInventor of Lorenzo's oil
Lorenzo Odone
BornLorenzo Michael Murphy Odone
(1978-05-29)May 29, 1978
Washington, D.C., U.S
DiedMay 30, 2008(2008-05-30) (aged 30)
Fairfax, Virginia, U.S
Known forAdrenoleukodystrophy patient

Augusto Daniel Odone (March 6, 1933 – October 24, 2013) and Michaela Teresa Murphy Odone (January 10, 1939 – June 10, 2000) were the parents of Lorenzo Michael Murphy Odone (May 29, 1978 – May 30, 2008), who had adrenoleukodystrophy (ALD). They became famous for developing a controversial treatment using Lorenzo's oil for their son's incurable illness. This quest was recounted in the film Lorenzo's Oil (1992).[1] Augusto had previously been an economist for the World Bank.[2]

In recognition of the parents' work, Augusto Odone received an honorary doctorate from the University of Stirling. He continued to raise funds and drive the scientific task force known as The Myelin Project until his death. Michaela Odone battled lung cancer for some time and died on June 10, 2000, at the age of 61.[3]

Lorenzo died the day after his 30th birthday. He was almost totally paralyzed but was, according to his father Augusto, "holding his own". He was unable to speak or move on his own. He communicated by wiggling his fingers and blinking his eyes. His mind was intact and he enjoyed music and having people read to him.[4] He lived with his father in Virginia and was cared for by nurses and his family friend, Oumouri Hassane.[5]

In mid-2010, two years after Lorenzo's death, Augusto Odone sold his home in Virginia and moved to Acqui Terme in his native Italy, near his father's village of Gamalero where he lived when he was young. He died there on 24 October 2013, at the age of 80.[6]

Background

[edit]

This severe form of adrenoleukodystrophy was first described by Ernst Siemerling and Hans Gerhard Creutzfeldt in 1923.[7] Lorenzo was diagnosed in April 1984, using a new blood test that had been recently developed. At the time, people diagnosed with the disease were usually young boys between 5 and 10 years old, who would gradually become mute, deaf, blind and paralysed before dying, which typically happened within two years due to aspiration or neurological causes.

Augusto and Michaela refused to accept this prognosis as final, and fought to find a treatment for the disease, often conflicting with doctors, specialist and support groups. With the help of Hugo Moser,[8] and through long hours of research and study, the Odones, who had had no previous medical background, came up with a treatment. This treatment involved the consumption of a specially prepared oil, which became known as "Lorenzo's oil".[9] Patients with a related condition, adrenomyeloneuropathy, showed no clinical improvement after being treated with Lorenzo's oil.[10]

The Odones had an important role in developing Lorenzo's oil and in setting up The Myelin Project, which promotes and carries out research on ALD and other similar disorders. Michaela also insisted on continuing to treat her incapacitated son as a human being and not a "vegetable", helping him devise a means of communicating with her and others through the blinking of his eyes and the wiggling of his fingers.

Cultural depictions

[edit]

The Odones' story was first depicted in the 1990 Italian television film Voglia di vivere, starring Tomas Milian and Dominique Sanda.[11] It was later made into the 1992 film Lorenzo's Oil, in which Augusto was played by Nick Nolte and Michaela by Susan Sarandon, who, through her involvement with the movie, became the spokesperson of The Myelin Project.

The 1994 episode of The Critic entitled "Dr. Jay", in which the main character Jay Sherman works to discover a cure for his boss's terminal disease, was a parody of the story.

A poem Michaela wrote about Lorenzo was set to music by Phil Collins. Titled "Lorenzo", the resulting song was featured on his 1996 album Dance into the Light.[12]

References

[edit]

Further reading

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Augusto, Michaela, and Lorenzo Odone

View on Grokipedia
from Grokipedia
Augusto Odone (1933–2013) and Michaela Odone (1939–2000) were an Italian-American couple renowned for their pioneering efforts in developing Lorenzo's Oil, an experimental treatment for their son Lorenzo Odone's rare genetic disorder, adrenoleukodystrophy (ALD), which dramatically extended his life beyond medical expectations. Born on March 6, 1933, in , , Augusto Odone was an economist who worked for the World Bank, while Michaela, born January 10, 1939, in the United States, supported the family during their international relocations due to his career. Their son, Lorenzo Michael Murphy Odone, was born on May 29, 1978, in the United States and showed early signs of exceptional intelligence and curiosity. In 1984, at the age of five, while the family was living in , Lorenzo was diagnosed with ALD, a progressive neurological disease that destroys the myelin sheath protecting nerve cells, primarily affecting young boys and typically leading to death within two years of symptom onset. Faced with a terminal prognosis and limited treatment options, Augusto and Michaela, neither of whom had medical training, abandoned their professional lives to immerse themselves in on and demyelinating diseases. They organized an international symposium on ALD in 1989 and collaborated with researchers, including a British chemist from Croda International, to formulate —a 4:1 mixture of (from ) and (from )—which normalizes elevated very long-chain fatty acids in the blood associated with ALD. Administered to Lorenzo starting in the late , the oil halted the progression of his disease, though it could not reverse existing neurological damage, leaving him in a and unable to speak or move voluntarily. Lorenzo defied predictions by surviving to age 30, dying on May 30, 2008, from , just one day after his birthday. Michaela continued caring for Lorenzo until her death from on June 10, 2000, after which Augusto, supported by caregiver Oumouri Hassane, took over and founded in 1990 to fund research into therapies for repair. Their story gained global attention through the 1992 film , directed by George Miller and starring and , which used its profits to support the project. Subsequent research validated aspects of their work: a 2005 study by the found that 74% of pre-symptomatic boys treated with avoided developing full ALD symptoms, establishing it as a preventive for at-risk individuals, though it remains experimental and is not a cure. Advances such as have since emerged, with a 2024 clinical trial showing long-term stabilization in most treated patients with cerebral ALD, furthering the Odones' advocacy for accelerated research. Augusto's legacy, continued through after his death on October 24, 2013, emphasizes and accelerated research into rare diseases.

Early Lives

Augusto's Background

Augusto Daniel Odone was born on March 6, 1933, in , , to Angelo Odone, a general in the , and Maria Odone. His family originated from the region, where he grew up in the small town of Gamalero near . Angelo Odone played a prominent role in the Italian resistance during World War II, which influenced the family's post-war circumstances in northern Italy. Odone pursued higher education in , becoming a polyglot Fulbright scholar with a focus on . He began his professional career as an economist, eventually joining the World Bank in , where he specialized in East African economies and contributed to financial planning initiatives in developing regions. His analytical expertise in economic modeling and laid a foundation for his later rigorous, data-driven approach to problem-solving. Prior to his second marriage, Odone wed Ulla Sjostrom on January 17, 1960, in Stockholm, Sweden, with whom he had two children: a son, Francesco, and a daughter, Cristina. The family immigrated to the United States in the late 1960s, when Odone relocated to Washington, D.C., for his position at the World Bank, seeking enhanced professional opportunities in international finance.

Michaela's Background

Michaela Teresa Murphy was born on January 10, 1939, in , to John Emmett Murphy and Mary Teresa O'Donnell. She received a bachelor's degree in French from Dunbarton College of the Sacred Heart in , in 1962, and also studied at the University of Grenoble in . Michaela developed a career as a linguist and translator, working in advertising and editorial roles at Realite magazine's offices in and New York. She became fluent in French, Italian, and Spanish, and was able to read Latin, abilities that facilitated her international professional engagements and later advocacy efforts.

Family Formation and Early Childhood

Marriage and Relocation

Augusto Odone, an Italian-born , relocated to , in 1969 with his first wife and two young children to take up a position at the World Bank, where he specialized in international economic development. This move established the family in the U.S. capital area, providing a stable base amid his career in global finance. In 1977, at the ages of 44 and 38 respectively, Odone married Michaela Teresa Murphy, a freelance editor and international real-estate from , in a ceremony there. Both entering the union later in life after Odone's previous marriage had ended in divorce, they blended their experiences, with Odone bringing his two children, and , while the couple initially had no children together. Their professional backgrounds in and afforded a comfortable lifestyle in the Washington region, allowing them to focus on building a unit.

Lorenzo's Early Years

Lorenzo Michael Murphy Odone was born on May 29, 1978, in , as the only child of Augusto Odone, an Italian-born economist with the World Bank, and Michaela Odone, an American-born linguist of Irish heritage. From infancy, Lorenzo showed signs of being a precocious , developing advanced reading skills and a keen social engagement marked by his articulate nature and love for performing. By age three, he was multilingual, fluent in English, Italian, and French, reflecting his enthusiasm for knowledge and preference for over typical nursery rhymes. His parents fostered this early talent by creating a supportive home environment, with leaving her editing job to focus on his care. The family's international lifestyle, shaped by Augusto's career, provided Lorenzo with broad exposure; soon after his third birthday in 1981, they relocated to the off Africa's east coast for his father's World Bank assignment, where he continued to thrive amid diverse cultural influences tied to his parents' Italian and Irish roots. In 1983, at age five, the Odones returned to the Washington area, settling in , where Lorenzo began his early education, displaying notable intelligence and eagerness in preschool activities.

Diagnosis and Disease Progression

Initial Symptoms and Diagnosis

In late 1983, at the age of five, Lorenzo Odone began exhibiting initial signs of a serious neurological condition, including behavioral changes such as increased hyperactivity and temper tantrums at school, slurred speech, stumbling due to coordination difficulties, and early indications of vision and hearing impairments. These symptoms emerged suddenly in an otherwise precocious and multilingual child, prompting concern from his parents, Augusto and Odone, who noted a decline from his previously robust health, including an incident where he fell off his new bicycle during the holidays. Throughout early 1984, the Odones sought medical evaluations from various specialists to address Lorenzo's worsening symptoms, leading to consultations at prominent institutions. On April 24, 1984, at in , Lorenzo was formally diagnosed with X-linked (ALD), a rare caused by mutations in the ABCD1 gene that impair the breakdown of very long-chain fatty acids, resulting in their accumulation and progressive destruction of the myelin sheath in the and . The diagnosis was confirmed through blood tests measuring elevated very long-chain fatty acid levels and neurological assessments, revealing the childhood cerebral form of the disease, which typically manifests between ages 4 and 10. ALD's childhood cerebral form carries a dire , with most affected boys experiencing rapid neurological deterioration leading to blindness, , , and death within approximately two years of symptom onset, often culminating in a without effective treatments available at the time. The Odone family was devastated by the news, as physicians at delivered the grim prediction of Lorenzo's swift decline, leaving the parents in profound shock and facing an incurable condition with no known interventions to halt its progression.

Impact on Family and Medical Challenges

Following Lorenzo's diagnosis with (ALD) in April 1984 at age five, the disease progressed rapidly, leading to severe neurological deterioration by 1986. Initial symptoms included behavioral changes such as temper tantrums, slurred speech, loss of balance, and bumping into objects, escalating to profound hearing and vision impairment, emotional instability, and motor difficulties due to demyelination of nerve fibers. By age eight, Lorenzo had entered a near-vegetative state, losing the ability to speak, walk, or control voluntary movements, becoming bedridden and virtually paralyzed. The Odone family adapted by establishing comprehensive , rejecting institutionalization to keep Lorenzo at home in . Michaela Odone, a former linguistic researcher, devoted herself full-time to his care, developing innovative communication methods such as interpreting eye blinks and subtle finger movements to convey Lorenzo's needs and responses. Augusto Odone arranged for medical equipment like feeding tubes and maintained routines involving and reading aloud, believing these preserved Lorenzo's cognitive engagement despite his physical limitations. These adaptations required constant vigilance, transforming their daily lives into a regimen of , monitoring, and emotional support. Frustrations with the medical establishment intensified the family's ordeal, as physicians offered no viable treatments and urged the Odones to place Lorenzo in an , citing the inevitability of his decline and their own limited progress. Doctors dismissed the family's inquiries into emerging therapies as overly complex or futile, exacerbating feelings of helplessness amid ALD's untreatable status at the time. Augusto later reflected on this disconnect, stating, “One problem with is that doctors think they know everything. In fact, they know very little.” The emotional and logistical toll on Augusto and Michaela was immense, marked by profound isolation from social circles and professional networks as they prioritized Lorenzo's care. Michaela sacrificed her career entirely, while Augusto, an economist at the World Bank, took extended leave and restructured his work to accommodate home responsibilities, straining their finances and personal well-being. The couple endured relentless grief and determination, with Augusto noting, “We love this kid, and we don’t want to lose him,” amid the psychological burden of watching their son's rapid decline without medical recourse.

Development of Lorenzo's Oil

Research Process

Following Lorenzo's diagnosis with (ALD) in 1984, Augusto and Odone, driven by their son's deteriorating condition, launched a rigorous self-directed investigation into potential treatments for the disease. Augusto, an at the World Bank with no formal medical or scientific background, resigned from his position that year to dedicate himself full-time to the effort, immersing himself in biochemistry through . He pored over at the library and , analyzing books, journals, and research on degradative enzymes and peroxisomal functions related to neurological disorders. contributed by leveraging her linguistic skills to translate dense scientific texts and correspond with global experts, forming the foundation of their investigative approach. A pivotal moment came at a conference organized by the Odones, where they convened leading researchers to discuss ALD mechanisms, during which they pinpointed the accumulation of very long-chain fatty acids (VLCFAs) as a core factor in the disease's . Drawing from emerging evidence in the literature, the Odones hypothesized that dietary interventions could inhibit VLCFA buildup in the and bloodstream, potentially slowing the demyelination process that destroys sheaths around fibers. This idea stemmed from their review of studies showing VLCFA elevation as a for ALD, leading them to propose using monounsaturated fatty acids to redirect metabolic pathways. To refine their hypothesis, the Odones sought collaborations with established experts, notably neurologist Dr. Hugo Moser at the , who had pioneered ALD diagnostics through VLCFA assays. Moser, initially skeptical, eventually tested their concepts in clinical settings, confirming that VLCFA levels could be lowered and validating the potential to delay neurological decline in presymptomatic cases. They also partnered with a British chemist, Don Suddaby, working at Croda International, to prototype mixtures based on their metabolic model. Throughout this process, the Odones encountered significant obstacles due to their lack of credentials and the scientific community's resistance. Medical professionals dismissed their ideas as amateurish, with some labeling the VLCFA inhibition theory "" and refusing to engage, viewing the couple as overreaching outsiders. Without institutional support or grants, they self-funded their work, including travel to conferences, lab testing, and early compound synthesis, often relying on personal savings and makeshift experiments. Despite these rejections, their persistence—rooted in exhaustive review of peer-reviewed papers and direct outreach to over 100 —gradually shifted some opinions, laying the groundwork for broader ALD research advancements.

Composition and Initial Use

Lorenzo's Oil was formulated as a 4:1 mixture of , derived from , and , derived from , specifically designed to inhibit the elongation of very long-chain fatty acids (VLCFAs) in patients with (ALD). This composition, equivalent to 80% oleic acid and 20% erucic acid, targeted the biochemical accumulation of VLCFAs believed to contribute to the disease's neurological damage. The Odones developed this blend based on their research into , aiming to normalize VLCFA levels without reversing existing loss. Administration of to Lorenzo Odone began in late 1986, following the family's collaboration with chemists to refine the . Given Lorenzo's advanced condition and inability to swallow, the was provided in daily oral doses mixed into his meals and delivered via a nasogastric tube, alongside a to enhance efficacy. Progress was closely monitored through regular blood tests to assess VLCFA concentrations, allowing the Odones to adjust the regimen as needed. By 1987, initial results demonstrated that the had stabilized Lorenzo's elevated VLCFA levels, effectively halting further biochemical deterioration in his system. However, it did not reverse the neurological damage already sustained, leaving him in a and unable to speak or move voluntarily. These early outcomes validated the oil's potential to inhibit progression at the metabolic level, though clinical benefits were limited for symptomatic patients like Lorenzo. Initially, the Odones sourced commercial and oils and prepared the mixture at home to ensure immediate availability for Lorenzo's treatment. As demand grew from other families, production shifted to professional manufacturing by Croda International, with the oil distributed under FDA compassionate use provisions as an experimental therapy, enabling access for ALD patients outside formal clinical trials.

Advocacy Efforts

Founding Organizations

In the late , following the development of , Augusto and Michaela Odone established informal networks with other parents of children affected by (ALD) to share experiences and resources, which laid the groundwork for organized efforts. These early parent support groups, formed amid limited medical options, evolved to push for improved diagnostics, including for programs to enable early detection of ALD; for example, sponsored California's Assembly Bill 1559, which passed unanimously in 2014 to add ALD to the state's newborn screening panel, contributing to national efforts that led to ALD's inclusion in the U.S. Recommended Uniform Screening Panel in 2016 and implementation across all states by 2023. In 1989, the Odones formally founded , an international dedicated to funding research on repair for ALD and other demyelinating diseases. Augusto Odone served as the director, overseeing the initiative's global operations from its base in the United States while coordinating efforts across multiple countries. The organization provided financial assistance to low-income families affected by ALD and extended support services to help families manage the disease's challenges. The Myelin Project forged partnerships with scientists and researchers worldwide, channeling funds raised through donations and awareness drives into targeted studies on and approaches to restore sheaths damaged by ALD. These collaborations emphasized practical, high-impact research to accelerate treatments beyond symptomatic management, reflecting the Odones' commitment to systemic change in care. In 2019, The Myelin Project merged with ALD Connect, a organization, to continue its mission of research funding, family support, and awareness for ALD under a unified structure.

Global Awareness Campaigns

The Odones actively raised global awareness of by organizing and participating in international medical conferences, where they challenged the slow pace of research and advocated for accelerated clinical trials. In the late 1980s, Augusto Odone convened experts from around the world for symposia on ALD, funding these events to foster collaboration among scientists and highlight the urgency of patient-driven innovation. At such gatherings, including those supported by they founded in 1989, the Odones delivered speeches emphasizing the need for faster therapeutic development, drawing on their personal experience to urge the medical community to prioritize rare diseases like ALD. Throughout the and , Augusto and Michaela Odone engaged in numerous media s and contributed to documentaries to educate the public about ALD and the challenges of rare diseases. Their appearances in outlets like television and print media humanized the struggle, reaching audiences worldwide and encouraging families affected by ALD to seek early intervention. For instance, in a , they discussed the development of and its potential to alter the disease's course, amplifying calls for broader research funding. The Odones also advocated for policy changes to facilitate access to , highlighting the role of compassionate use programs for experimental therapies in rare conditions, influencing discussions on regulatory flexibility despite the oil's ultimate as an unapproved investigational treatment. Through international travel facilitated by Augusto's World Bank background and the Myelin Project's , the Odones connected with affected families across continents, promoting patient-led research and sharing strategies for managing ALD. These journeys, spanning , , and , built a worldwide of advocates and underscored the importance of cross-border collaboration in combating orphan diseases.

Later Years and Deaths

Michaela's Final Years

In the late 1990s, Michaela Odone began battling , which progressively weakened her despite her unwavering dedication to her family. Despite the toll of her illness, she continued providing intensive daily care for her son Lorenzo, who remained paralyzed and nonverbal due to (ALD). Odone spent up to 16 hours a day at his bedside, employing the finger-wiggling and eyebrow-raising communication methods she had developed with him over the years, even as her own strength diminished. This relentless caregiving, which Augusto Odone later attributed to straining her and contributing to her cancer's severity, underscored her profound sacrifice. Throughout her final months, Odone persisted in her advocacy for ALD research as co-founder of , established in 1989 to fund therapies for demyelinating diseases like her son's. She remained actively involved in the organization's efforts to promote clinical trials and awareness, drawing on the global attention from the 1992 film to secure support for ongoing studies. Her work emphasized patient-driven innovation, inspiring researchers to explore remyelination techniques even as her health declined. Michaela Odone died on June 10, 2000, at the age of 61, in her home in , from . Her passing profoundly altered the family dynamics, leaving Augusto as the sole primary caregiver for Lorenzo and intensifying the emotional and logistical burdens of their routine.

Lorenzo's Prolonged Survival and Death

Following his diagnosis with (ALD) in 1984 at age six, Lorenzo Odone defied medical predictions of a two-year survival, living for 24 additional years until 2008, making him likely the longest-surviving individual with the condition at that time. The family's development and administration of is credited with stabilizing his condition and enabling this prolonged life, though it did not reverse the disease's progression. By the late , Lorenzo was completely , blind, , and paralyzed, unable to swallow or move voluntarily, yet he remained at home in , under 24-hour care to manage his needs. Despite his severe disabilities, Lorenzo retained some awareness and communicated basic affirmations or negations through eye blinks and finger wiggles, responding to stimuli in ways that suggested his cognitive faculties were intact. His family observed his apparent enjoyment of music, reading sessions, and physical massages, interpreting these reactions as signs of enduring mental presence and determination to live. This perceived awareness deepened the family's emotional bond, with caregivers treating him as fully engaged in their shared life, fostering a routine centered on comfort and . After Odone's death from in 2000, primary caregiving shifted to his father Augusto and longtime aide Oumouri Hassane, a family friend from the Islands whom the Odones had met during an earlier posting, supported by rotating nurses. Their daily routine involved tube feedings five times a day, frequent suctioning of to prevent aspiration, gentle exercises to prevent contractures, playing favorite music, twice-weekly readings by volunteer Ann Davidson, and visits from children to maintain a lively environment; the home was adapted with foam padding on corners for safety during transfers. This devoted care underscored the family's unwavering commitment, viewing Lorenzo's persistence as a testament to their unbreakable connection. The family marked Lorenzo's 30th birthday on May 29, 2008—his birthdate in 1978—with a celebration at home, but he died the next day, May 30, from complications of related to a obstruction. In reflections shared by his sister Cristina, Lorenzo's unyielding will to survive, evident in his daily endurance, not only sustained the family through decades of hardship but also reinforced their profound sense of unity and purpose.

Augusto's Continued Work and Passing

Following the deaths of his wife in 2000 and son Lorenzo in 2008, Augusto Odone persisted in his advocacy for repair research, leading remotely from the for several more years despite declining health. He focused on fundraising and coordinating international scientific efforts to advance treatments for adrenoleukodystrophy (ALD) and related disorders, emphasizing remyelination therapies that could restore nerve function. In mid-2010, two years after Lorenzo's passing, Odone sold his home in , and relocated to in , , his childhood region near the village of Gamalero, to be closer to family and roots. From there, he maintained oversight of , directing its operations through collaborators while adapting to his new circumstances. During this period, he received care from longtime aide Oumouri Hassane and children from his first marriage, allowing him to reflect on his life's work. Odone's contributions were formally recognized earlier with an honorary Doctor of the University degree from the University of Stirling on March 2, 1991, honoring his pioneering role in patient-driven medical innovation. In 2013, he published his memoir Lorenzo and His Parents: The Full and True Story of the Odones and Their Race Against the Mysterious and Deadly Disease That Was Destroying Their Five-Year-Old Son, which chronicled the family's battle against ALD, the development of Lorenzo's Oil, and the broader implications for medical research. Augusto Odone died on October 24, 2013, at the age of 80 in , , from organ failure precipitated by a lung infection. His passing marked the end of an era for , which he had sustained through personal determination long after his immediate family's losses.

Cultural and Scientific Legacy

Media Depictions

The story of Augusto, Michaela, and Lorenzo Odone has been depicted in several media works, beginning with an Italian television film and culminating in a prominent Hollywood production. The first adaptation was the 1990 Italian TV movie Voglia di Vivere (Desire to Live), directed by Lodovico Gasparini, which portrayed the family's early struggles with Lorenzo's (ALD). Starring as Augusto Odone and as Michaela Odone, the film focused on their initial diagnosis and determination to seek treatment, airing on Italian television before the international attention garnered by later works. The most widely recognized portrayal is the 1992 feature film , directed and co-written by George Miller, which dramatized the Odones' quest to develop a treatment for their son's condition. In the film, played Augusto Odone as a tenacious challenging medical authorities, while portrayed Michaela as a fiercely devoted mother, earning her an Academy Award nomination for . The movie also received a nomination for Best Original Screenplay at the , highlighting its narrative impact despite a modest performance of $7.3 million domestically against a $30 million budget. Beyond films, the Odones' experiences were chronicled in print media, including Augusto's 2012 memoir Lorenzo and His Parents: The True Story of a Family's Fight Against a Fatal Disease, which provided a personal account of the family's challenges and triumphs from his perspective. Following Augusto's death in 2013, major obituaries in outlets such as The New York Times, The Guardian, and The Telegraph reflected on the family's story, emphasizing their unconventional approach to Lorenzo's care and its broader implications for patient advocacy. Debates over the accuracy of these depictions center on the films' narrative choices, which condensed and dramatized timelines for emotional effect. For instance, Lorenzo's Oil portrayed the Odones' research breakthroughs as occurring in a compressed period, whereas in reality, their work on the oil mixture spanned years of trial and collaboration with scientists. Michaela Odone specifically contested scenes depicting her as physically aggressive, such as slapping her husband or ejecting family members, stating these were fictionalized for dramatic tension rather than reflecting actual events. While the film accurately captured the family's isolation and persistence, critics and the Odones themselves noted that it overstated the oil's immediate efficacy against ALD progression, diverging from the more nuanced real-life outcomes where Lorenzo's survival extended but the disease persisted.

Ongoing Impact on ALD Research

The Odones' establishment of in 1989 has had a sustained influence on (ALD) research through its merger with ALD Connect, which continues to fund innovative therapies. Since the merger, ALD Connect has provided financial support exceeding several million dollars for ALD initiatives, including grants to emerging investigators and patient support programs that have enabled participation in clinical trials. Notably, post-2013 efforts have backed trials, such as those exploring lentiviral vectors to address the ABCD1 gene mutation underlying ALD, contributing to advancements in potential curative approaches, including the 2022 FDA accelerated approval of Skysona (elivaldogene autotemcel), the first therapy shown to slow neurologic progression in boys with early, active cerebral ALD. Lorenzo's Oil, developed by Augusto Odone, plays a key role in managing ALD by normalizing very long-chain (VLCFA) levels in plasma, which has proven effective in preventing neurological symptoms in many asymptomatic boys when initiated early. A long-term study of 89 asymptomatic boys treated with the oil showed that 74% remained symptom-free over follow-up periods averaging 3.7 years, with reduced risk of developing cerebral ALD lesions on MRI. This preventive potential is amplified by widespread for ALD, now mandated in 46 U.S. states and the District of Columbia as of 2025, allowing presymptomatic intervention with the oil to avert onset in affected males. The Odones' advocacy has broadly shaped policy, exemplifying patient-driven involvement that accelerated FDA processes for and encouraged family participation in research design. Their efforts highlighted the need for expedited approvals under the Orphan Drug Act framework, influencing subsequent reforms that prioritize patient input to streamline therapy development for conditions like ALD. This model has fostered greater collaboration between families, researchers, and regulators, leading to faster pathways for treatments. Debates persist regarding Lorenzo's Oil's overall , as it effectively lowers VLCFA accumulation but does not reverse existing neurological or halt progression in symptomatic patients. International guidelines note insufficient from controlled trials to confirm it as a standalone -modifying , though it offers modest risk reduction when used preventively. Optimal outcomes are achieved by combining it with (HSCT) in early cerebral ALD cases, where the oil supports biochemical stabilization alongside HSCT's immunomodulatory effects to improve survival and stabilize function.

References

  1. https://www.theguardian.com/society/2013/nov/01/augusto-odone
  2. https://www.bbc.com/news/world-europe-24676384
  3. https://www.mcgill.ca/oss/article/medical-history-did-you-know/lorenzos-oil-contributed-treatment-devastating-disease
  4. https://www.nytimes.com/2013/10/29/world/europe/augusto-odone-father-behind-real-life-lorenzos-oil-dies-at-80.html
  5. https://www.nytimes.com/2000/06/13/us/michaela-odone-61-the-lorenzo-s-oil-mother.html
  6. https://www.newscientist.com/article/dn14060-obituary-lorenzo-odone/
  7. https://www.theguardian.com/science/2008/jun/04/medicalresearch.genetics
  8. https://www.thelancet.com/journals/lancet/article/PIIS0140673609605341/fulltext
  9. https://ulf.org/resources/lorenzos-oil/
  10. https://www.massgeneralbrigham.org/en/about/newsroom/press-releases/gene-therapy-shows-long-term-benefit-for-patients-with-rare-pediatric-brain-disease
  11. https://www.economist.com/obituary/2013/11/16/augusto-odone
  12. https://ancestors.familysearch.org/en/LJL2-1SQ/augusto-daniel-odone-1933-2013
  13. https://www.telegraph.co.uk/news/obituaries/culture-obituaries/10402968/Augusto-Odone.html
  14. https://ancestors.familysearch.org/en/LJL2-BGV/michaela-teresa-murphy-1939-2000
  15. https://www.nytimes.com/1977/07/15/archives/michaela-murphy-editor-married-to-augusto-odone.html
  16. https://www.sun-sentinel.com/2000/06/12/michaela-odone-61-inspired-lorenzos-oil/
  17. https://www.chicagotribune.com/1993/01/22/lorenzos-oil-stirs-up-troubled-waters-for-families-of-ald/
  18. https://www.telegraph.co.uk/news/obituaries/2062622/Obituary-Lorenzo-Odone.html
  19. https://www.washingtonpost.com/archive/lifestyle/1991/08/01/in-pursuit-of-a-miracle/33ebc579-47ab-4491-bcc0-a5255bec1ab4/
  20. https://www.washingtonpost.com/archive/local/2002/11/17/a-balm-for-the-afflicted/07fcfbe2-bf23-44bc-a8e3-956b815aa3d7/
  21. https://drbarronlerner.com/the-father-who-fought-for-lorenzos-oil/
  22. https://www.washingtonpost.com/archive/local/1984/09/21/fatally-ill/9cf1d7d8-417a-474b-9376-60599988b5a2/
  23. https://medlineplus.gov/genetics/condition/x-linked-adrenoleukodystrophy/
  24. https://www.mayoclinic.org/diseases-conditions/adrenoleukodystrophy/symptoms-causes/syc-20369157
  25. https://rarediseases.org/rare-diseases/adrenoleukodystrophy/
  26. https://www.theguardian.com/lifeandstyle/2002/oct/15/healthandwellbeing.health
  27. https://archive.nytimes.com/well.blogs.nytimes.com/2013/10/30/the-father-who-fought-for-lorenzos-oil/
  28. https://www.latimes.com/local/obituaries/la-me-augusto-odone-20131025-story.html
  29. https://www.guidestar.org/profile/52-1545992
  30. https://pmc.ncbi.nlm.nih.gov/articles/PMC6715319/
  31. http://www.thefriedlandergroup.com/the-myelin-project.3-66-1130.sub.html
  32. https://checkorphan.org/network/myelin-project/
  33. https://aldconnect.org/news/ald-connect-joins-forces-with-the-myelin-project/
  34. https://www.youtube.com/watch?v=A10eSXXF2No
  35. https://www.verywellhealth.com/what-islorenzos-oil-2860830
  36. https://www.newscientist.com/article/dn2851-lorenzos-oil-finally-proven-to-work/
  37. https://www.washingtonpost.com/archive/local/2000/06/12/michaela-odone-dies/10fe238c-abb0-461c-b828-8686928e7619/
  38. https://www.newscientist.com/article/mg17323274-700-lessons-from-lorenzo/
  39. https://www.latimes.com/archives/la-xpm-2000-jun-12-me-40195-story.html
  40. http://www.law.uh.edu/healthlaw/perspectives/Research/020715Fortune.html
  41. https://www.smh.com.au/national/dying-son-inspired-a-dramatic-quest-of-love-20080606-gdsgq3.html
  42. https://www.italyonthisday.com/2018/03/augusto-odone-Lorenzos-Oil-medical-pioneer.html
  43. https://www.stir.ac.uk/events/graduation/honorary-graduates/
  44. https://www.boxofficemojo.com/title/tt0104756/
  45. https://www.imdb.com/title/tt0104756/awards/
  46. https://www.acpjournals.org/doi/10.7326/0003-4819-133-7-200010030-00030
  47. https://www.baltimoresun.com/1993/01/26/troubled-waters-for-lorenzos-oil-fact-based-movie-took-too-much-license-real-characters-contend/
  48. https://aldconnect.org/news/ald-connect-launches-breakthrough-research-fund-to-accelerate-scientific-discovery/
  49. https://aldconnect.org/clinical-trials-and-research/emerging-investigators/
  50. https://aldconnect.org/news/bluebird-bio-receives-fda-accelerated-approval-for-skysona-gene-therapy/
  51. https://jamanetwork.com/journals/jamaneurology/fullarticle/788970
  52. https://pubmed.ncbi.nlm.nih.gov/16009761/
  53. https://www.aldalliance.org/newborn-screening.html
  54. https://rarediseases.org/the-orphan-drug-act-turns-40-nord-celebrates-its-impact-on-rare-diseases/
  55. https://www.dovepress.com/a-30-year-retrospective-national-organization-for-rare-disorders-the-o-peer-reviewed-fulltext-article-ODRR
  56. https://www.neurology.org/doi/10.1212/WNL.0000000000201374
  57. https://pmc.ncbi.nlm.nih.gov/articles/PMC4390468/
Add your contribution
Related Hubs
User Avatar
No comments yet.